Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

๐ŸŒ CNBC (United States) —
Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

AI Summary

Novonesis is exploring gut-health supplements for people taking GLP-1 weight-loss drugs. The effort could create a new commercial opportunity as use of these medications grows.

Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.

Markets Health Novonesis GLP-1 weight-loss drugs gut health supplements healthcare market

Read original source →